Multiple Sclerosis Therapeutics Market Analysis By Drug Class (Immunosuppressants, Immunostimulants, Interferons and Others), By Route of Administration (Oral, Injectable and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and E-Commerce), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2024
- Report ID: 135902
- Number of Pages: 289
- Format:
-
keyboard_arrow_up
-
-
- Acorda Therapeutics Inc.
- Bayer AG Company Profile
- Biogen
- Bristol-Myers Squibb Company
- Hoffmann-La Roche Ltd
- Horizon Therapeutics plc
- Johnson & Johnson Services Inc. (Janssen Global Services LLC)
- Merck & Co., Inc.
- Merck KGaA Company Profile
- Novartis AG Company Profile
- Pfizer Inc Company Profile
- Sanofi SA
- Takeda Pharmaceutical Company Limited.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Viatris Inc. (Mylan NV)
Our Clients
- 135902
- Dec 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
